Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Folic Acid-Doxorubicin-Double-Functionalized-Lipid-Core Nanocapsules: Synthesis, Chemical Structure Elucidation, and Cytotoxicity Evaluation on Ovarian (OVCAR-3) and Bladder (T24) Cancer Cell Lines.
Cé R, Lavayen V, Couto GK, De Marchi JGB, Pacheco BZ, Natividade LA, Fracari TO, Ciocheta TM, de Cristo Soares Alves A, Jornada DS, Guterres SS, Seixas F, Collares T, Pohlmann AR. Cé R, et al. Among authors: lavayen v. Pharm Res. 2021 Feb;38(2):301-317. doi: 10.1007/s11095-021-02989-y. Epub 2021 Feb 19. Pharm Res. 2021. PMID: 33608808
Bromelain-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Formulation, Chemical Structure and Antiproliferative Effect Against Human Breast Cancer Cells (MCF-7).
Oliveira CP, Prado WA, Lavayen V, Büttenbender SL, Beckenkamp A, Martins BS, Lüdtke DS, Campo LF, Rodembusch FS, Buffon A, Pessoa A Jr, Guterres SS, Pohlmann AR. Oliveira CP, et al. Among authors: lavayen v. Pharm Res. 2017 Feb;34(2):438-452. doi: 10.1007/s11095-016-2074-2. Epub 2016 Dec 15. Pharm Res. 2017. PMID: 27981451
Chitosan-Coated Lipid-Core Nanocapsules Functionalized with Gold-III and Bevacizumab Induced In Vitro Cytotoxicity against C6 Cell Line and In Vivo Potent Antiangiogenic Activity.
de Cristo Soares Alves A, Lavayen V, Figueiró F, Dallemole DR, de Fraga Dias A, Cé R, Battastini AMO, Guterres SS, Pohlmann AR. de Cristo Soares Alves A, et al. Among authors: lavayen v. Pharm Res. 2020 May 8;37(6):91. doi: 10.1007/s11095-020-02804-0. Pharm Res. 2020. PMID: 32385723
EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma.
de Cristo Soares Alves A, Lavayen V, de Fraga Dias A, Bruinsmann FA, Scholl JN, Cé R, Visioli F, Oliveira Battastini AM, Stanisçuaski Guterres S, Figueiró F, Raffin Pohlmann A. de Cristo Soares Alves A, et al. Among authors: lavayen v. Nanomedicine (Lond). 2021 Aug;16(20):1775-1790. doi: 10.2217/nnm-2021-0169. Epub 2021 Jul 27. Nanomedicine (Lond). 2021. PMID: 34313137
Synthesis of films based on chitosan and protic ionic liquids to be used as wound dressing on the oral mucosa.
Medeiros L, Dos Santos RF, da Rolt Nervis B, Jacobi M, Hashizume LN, Gazzi RP, Visioli F, Nunes JS, Lavayen V, De Franco VC, Daitx TS, Pereira SC, Ferreira GA, Pohlmann A, Guterres S, Frank LA, Bussamara R. Medeiros L, et al. Among authors: lavayen v. Int J Biol Macromol. 2023 Dec 31;253(Pt 6):127134. doi: 10.1016/j.ijbiomac.2023.127134. Epub 2023 Sep 28. Int J Biol Macromol. 2023. PMID: 37776933
Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency.
Carvalho Feitosa R, Souza Ribeiro Costa J, van Vliet Lima M, Sawa Akioka Ishikawa E, Cogo Müller K, Bonin Okasaki F, Sabadini E, Garnero C, Longhi MR, Lavayen V, da Silva-Júnior AA, Oliveira-Nascimento L. Carvalho Feitosa R, et al. Among authors: lavayen v. Pharmaceutics. 2023 Apr 19;15(4):1285. doi: 10.3390/pharmaceutics15041285. Pharmaceutics. 2023. PMID: 37111770 Free PMC article.
18 results